OKLINE CAPITAL MARKETS A Division of CIM Securities Veru, Inc. (VERWI April 05, 2018 Portfolio Manager's Summary Focus on Developing Urology and Oncology Products Leveraging 505(b)(2) Veru is a biopharmaceutical company with a focus on developing products in Urology (including a female sexual health division) and Oncology. It ha